Acute Pancreatitis Alert & Decision Support Improves Care & Cuts Length of Stay
急性胰腺炎警报
基本信息
- 批准号:9112050
- 负责人:
- 金额:$ 20.34万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-04-09 至 2018-03-31
- 项目状态:已结题
- 来源:
- 关键词:Accident and Emergency departmentAcuteAddressAgeAlcoholsBiological SciencesCaringCessation of lifeCharacteristicsCigaretteClinicalClinical DataClinical ResearchComorbidityComputerized Medical RecordDataData AnalysesData CollectionDiagnosisDigestive System DisordersEmergency Department PhysicianEtiologyEvaluationFrequenciesFundingGenerationsGoalsGuidelinesHospitalizationHospitalsInformation TechnologyInstitutionInternetLength of StayLinkLiquid substanceMeasuresMedicalMedical StudentsMedical centerMethodsMichiganModelingNecrosisNotificationNursesOnline SystemsOperative Surgical ProceduresOrgan failureOutcomePancreasPatientsPenetrationPhaseProcessPublicationsQuality of CareRecommendationReportingResearchResearch DesignResearch InfrastructureResuscitationRiskSafetySavingsSeveritiesSoftware ToolsSourceSpecialistStagingStratificationSystemTechnologyTestingTextTimeTranslational ResearchWorkacute pancreatitisbaseclinical decision-makingcommercializationcostdesignfeedinggastrointestinalimprovedimproved outcomeiterative designmeetingsmembermortalitymultidisciplinarynutritionpoint of careprogramsprospectivepublic health relevanceradiologistresearch studyresponsesupport toolstooltreatment response
项目摘要
DESCRIPTION (provided by applicant): The long-term goal of this research is to develop a portable, scalable software tool to improve treatment for patients with acute pancreatitis (AP). Funds are requested in this R21 proposal to support a 300 patient study using the second generation of The AP Early Response (TAPER)-Clinical Decision Support (CDS)-Tool. The expected outcome is that use of version 2.0 of the TAPER-CDS-Tool will result in increased compliance with accepted clinical guidelines, improved clinical outcome, and lower hospitalization costs for AP patients. AP is the most common reason for gastrointestinal-related hospitalizations. Although accepted clinical guidelines for managing AP exist, compliance with these recommendations is generally poor. Our multidisciplinary quality improvement (QI) team developed the TAPER-CDS-Tool 1.0, which is a combined early automated paging-alert system, which text-pages emergency department (ED) clinicians about a patient with possible AP, and an intuitive, concise web-based point-of-care guide consisting of 7-early management recommendations. In our preliminary study comparing pre and post TAPER-CDS-Tool 1.0 periods involving 223 patients, this Tool associated with increased implementation of 2 of 7-recommendations (fluid resuscitation and risk stratification), and a mean decrease in hospital length-of-stay (LOS) by 2.1 days, associated with savings of $3,874/hospitalization. Although Tool 1.0 significantly improved outcomes and reduced cost of AP, 4 of 7 best practices for AP treatment had poor penetration and only 2 of these 4 improved significantly. Thus, we refined Tool 1.0 to address these shortcomings, and now intend to evaluate the refined TAPER-CDS- Tool 2.0 as the focus of this proposal. The TAPER-CDS-Tool 2.0 is a scalable QI tool intended for widespread use in the ED and during hospitalization to achieve the goals of increased process and quality of care and improved outcomes, specifically shortened hospital LOS. With the expertise of our Information Technology Application Programmer, we focused on integrating Tool 2.0 into the electronic medical record (EMR) as a single source of best practice alerts (BPA) to "feed forward" key information to users to support real-time clinical decision making at various stages of care: 1) alert notification about the diagnosis of AP, 2) a time-based automated assessment of severity, 3) a time-based automated display of patient specific clinical data showing the response to treatments and 4) an embedded link to the CDS-Tool, containing guideline and institutional recommendations encompassing ED and hospital care. The BPA overcomes limitations of Tool 1.0 by expanding the alert notification to all ED & hospital clinicians, trainees and nurses rather than just ED clinicians and trainees. We anticipate that results from this project will demonstrate an effective, scalable method for implementing clinical guidelines by interfacing with EMR infrastructures, which have been rolled-out for use nationally. Data gathered from this study will be pivotal to design a validating prospective RCT. In the long term, we aim to harness this platform technology and the iterative refinement strategy to develop guideline implementation methods to improve process of care and outcomes for other acute illnesses.
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MATTHEW J DIMAGNO其他文献
MATTHEW J DIMAGNO的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MATTHEW J DIMAGNO', 18)}}的其他基金
Acute Pancreatitis Alert & Decision Support Improves Care & Cuts Length of Stay
急性胰腺炎警报
- 批准号:
9258434 - 财政年份:2016
- 资助金额:
$ 20.34万 - 项目类别:
Inflammatory response to pancreatitis in CF mice: sodium & impaired apoptosis
CF 小鼠胰腺炎的炎症反应:钠
- 批准号:
7896306 - 财政年份:2009
- 资助金额:
$ 20.34万 - 项目类别:
Pioglitazone Therapy for Endocrine and Exocrine Disease in Alcoholic Pancreatitis
吡格列酮治疗酒精性胰腺炎内分泌和外分泌疾病
- 批准号:
7664617 - 财政年份:2008
- 资助金额:
$ 20.34万 - 项目类别:
Pioglitazone Therapy for Endocrine and Exocrine Disease in Alcoholic Pancreatitis
吡格列酮治疗酒精性胰腺炎内分泌和外分泌疾病
- 批准号:
7532232 - 财政年份:2008
- 资助金额:
$ 20.34万 - 项目类别:
Inflammatory response to pancreatitis in CF mice: sodium & impaired apoptosis
CF 小鼠胰腺炎的炎症反应:钠
- 批准号:
7637484 - 财政年份:2006
- 资助金额:
$ 20.34万 - 项目类别:
Inflammatory response to pancreatitis in CF mice: sodium & impaired apoptosis
CF 小鼠胰腺炎的炎症反应:钠
- 批准号:
7432601 - 财政年份:2006
- 资助金额:
$ 20.34万 - 项目类别:
Inflammatory response to pancreatitis in CF mice: sodium & impaired apoptosis
CF 小鼠胰腺炎的炎症反应:钠
- 批准号:
7252069 - 财政年份:2006
- 资助金额:
$ 20.34万 - 项目类别:
Inflammatory response to pancreatitis in CF mice: sodium & impaired apoptosis
CF 小鼠胰腺炎的炎症反应:钠
- 批准号:
7883673 - 财政年份:2006
- 资助金额:
$ 20.34万 - 项目类别:
Inflammatory response to pancreatitis in CF mice: sodium & impaired apoptosis
CF 小鼠胰腺炎的炎症反应:钠
- 批准号:
7147051 - 财政年份:2006
- 资助金额:
$ 20.34万 - 项目类别:
eNOS is Protective in the Initiation of Pancreatitis
eNOS 在胰腺炎的发生过程中具有保护作用
- 批准号:
6487168 - 财政年份:2003
- 资助金额:
$ 20.34万 - 项目类别:
相似海外基金
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 20.34万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 20.34万 - 项目类别:
Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 20.34万 - 项目类别:
Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 20.34万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 20.34万 - 项目类别:
Standard Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 20.34万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 20.34万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 20.34万 - 项目类别:
Research Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 20.34万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
- 批准号:
484000 - 财政年份:2023
- 资助金额:
$ 20.34万 - 项目类别:
Operating Grants














{{item.name}}会员




